![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1349, 2002-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ketolides in the treatment of respiratory infections
By Hoban Daryl J Zhanel George G
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Iclaprim: a new weapon in the fight against bacterial resistance
Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bevacizumab a new weapon in the fight against renal cancer
Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Review of Macrolides and Ketolides: Focus on Respiratory Tract Infections
By Zhanel G.G.
Drugs, Vol. 61, Iss. 4, 2001-01 ,pp. :